Glenn Frank Short
CIK 2049070 · Chief Scientific Officer · last filed 2026-02-03
Glenn Frank Short is a Chief Scientific Officer who has filed 5 SEC Form 4 insider transactions across 1 company since 2025. Across all open-market trades the lifetime net is −$17.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $312.8K across reported positions. 5 SEC filings were submitted jointly with ATAI Life Sciences N.V.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$312.8K
1
5
-$17.8K
Filer Profile
WALLSTRASSE 16
BERLIN, 2M 10179
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ATAI | Chief Scientific Officer | 42,333 | $7.39 | $312.8K | -$17.8K | 3 | 2025-03-24 |
Recent Filings
5 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-03 | — | Grant (A) | — | $0 | |
| 2025-03-24 | ATAI | Sell (S) | −13,161 | -$17.8K | EDGAR |
| 2025-03-21 | — | Notice (144) | −13,161 | -$18.3K | EDGAR |
| 2025-03-19 | ATAI | Exer (M) | +32,500 | $0 | EDGAR |
| 2025-03-06 | ATAI | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.